Cargando…
The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: Social Media Review
BACKGROUND: Adult patients with acute lymphoblastic leukemia (ALL) report substantial disease- and treatment-related impacts on their health-related quality of life (HRQOL). Patient-reported information (PRI) shared on social media may provide a distinct opportunity to understand the patient experie...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186186/ https://www.ncbi.nlm.nih.gov/pubmed/37126376 http://dx.doi.org/10.2196/39852 |
_version_ | 1785042512417652736 |
---|---|
author | Crawford, Rebecca Sikirica, Slaven Morrison, Ross Cappelleri, Joseph C Russell-Smith, Alexander Shah, Richa Chadwick, Helen Doward, Lynda |
author_facet | Crawford, Rebecca Sikirica, Slaven Morrison, Ross Cappelleri, Joseph C Russell-Smith, Alexander Shah, Richa Chadwick, Helen Doward, Lynda |
author_sort | Crawford, Rebecca |
collection | PubMed |
description | BACKGROUND: Adult patients with acute lymphoblastic leukemia (ALL) report substantial disease- and treatment-related impacts on their health-related quality of life (HRQOL). Patient-reported information (PRI) shared on social media may provide a distinct opportunity to understand the patient experience outside of formal research contexts and help inform the development of novel therapies. OBJECTIVE: This qualitative social media review aimed to assess PRI shared on social media websites to gain a better understanding of the symptom, HRQOL, and treatment impacts on individuals with ALL. METHODS: We identified English-language posts on 3 patient advocacy websites (Patient Power, The Patient Story, and Leukaemia Care) and YouTube that included PRI about experiences with ALL or ALL treatments shared by adults (aged ≥18 years) with a self-reported ALL diagnosis. Patients’ demographic and disease characteristics were extracted from posts (where available), and the posts were analyzed thematically. A network analysis was conducted to delineate possible associations among ALL symptoms, HRQOL impacts, and treatment-related symptoms and impacts. RESULTS: Of the 935 social media posts identified, 63 (7%) met the review criteria, including 40 (63%) videos, 5 (8%) comments posted in response to videos, and 18 (29%) blog posts. The 63 posts were contributed by 41 patients comprised of 21 (51%) males, 18 females (44%), and 2 (5%) whose gender was not reported. Among the patients, 13 (32%) contributed >1 source of data. Fatigue (n=20, 49%), shortness of breath (n=13, 32%), and bruising (n=12, 29%) were the symptoms prior to treatment most frequently discussed by patients. Patients also reported impacts on personal relationships (n=26, 63%), psychological and emotional well-being (n=25, 61%), and work (n=16, 39%). Although inpatient treatment reportedly restricted patients’ independence and social functioning, it also provided a few patients with a sense of safety. Patients frequently relied on their doctors to drive their treatment decisions but were also influenced by family members. The network analysis indicated that disease-related symptoms were primarily associated with patients’ physical functioning, activities of daily living, and ability to work, while treatment-related symptoms were primarily associated with emotional well-being. CONCLUSIONS: This social media review explored PRI through a thematic analysis of patient-contributed content on patient advocacy websites and YouTube to identify and contextualize emergent themes in patient experiences with ALL and its treatments. To our knowledge, this is the first study to leverage this novel tool to generate new insights into patients’ experiences with ALL. Patients’ social media posts suggest that inpatient care for ALL is associated with restricted independence and social functioning. However, inpatient care also provided a sense of safety for some patients. Studies such as this one that capture patients’ experiences in their own words are valuable tools to further our knowledge of patient outcomes with ALL. |
format | Online Article Text |
id | pubmed-10186186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-101861862023-05-17 The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: Social Media Review Crawford, Rebecca Sikirica, Slaven Morrison, Ross Cappelleri, Joseph C Russell-Smith, Alexander Shah, Richa Chadwick, Helen Doward, Lynda JMIR Cancer Original Paper BACKGROUND: Adult patients with acute lymphoblastic leukemia (ALL) report substantial disease- and treatment-related impacts on their health-related quality of life (HRQOL). Patient-reported information (PRI) shared on social media may provide a distinct opportunity to understand the patient experience outside of formal research contexts and help inform the development of novel therapies. OBJECTIVE: This qualitative social media review aimed to assess PRI shared on social media websites to gain a better understanding of the symptom, HRQOL, and treatment impacts on individuals with ALL. METHODS: We identified English-language posts on 3 patient advocacy websites (Patient Power, The Patient Story, and Leukaemia Care) and YouTube that included PRI about experiences with ALL or ALL treatments shared by adults (aged ≥18 years) with a self-reported ALL diagnosis. Patients’ demographic and disease characteristics were extracted from posts (where available), and the posts were analyzed thematically. A network analysis was conducted to delineate possible associations among ALL symptoms, HRQOL impacts, and treatment-related symptoms and impacts. RESULTS: Of the 935 social media posts identified, 63 (7%) met the review criteria, including 40 (63%) videos, 5 (8%) comments posted in response to videos, and 18 (29%) blog posts. The 63 posts were contributed by 41 patients comprised of 21 (51%) males, 18 females (44%), and 2 (5%) whose gender was not reported. Among the patients, 13 (32%) contributed >1 source of data. Fatigue (n=20, 49%), shortness of breath (n=13, 32%), and bruising (n=12, 29%) were the symptoms prior to treatment most frequently discussed by patients. Patients also reported impacts on personal relationships (n=26, 63%), psychological and emotional well-being (n=25, 61%), and work (n=16, 39%). Although inpatient treatment reportedly restricted patients’ independence and social functioning, it also provided a few patients with a sense of safety. Patients frequently relied on their doctors to drive their treatment decisions but were also influenced by family members. The network analysis indicated that disease-related symptoms were primarily associated with patients’ physical functioning, activities of daily living, and ability to work, while treatment-related symptoms were primarily associated with emotional well-being. CONCLUSIONS: This social media review explored PRI through a thematic analysis of patient-contributed content on patient advocacy websites and YouTube to identify and contextualize emergent themes in patient experiences with ALL and its treatments. To our knowledge, this is the first study to leverage this novel tool to generate new insights into patients’ experiences with ALL. Patients’ social media posts suggest that inpatient care for ALL is associated with restricted independence and social functioning. However, inpatient care also provided a sense of safety for some patients. Studies such as this one that capture patients’ experiences in their own words are valuable tools to further our knowledge of patient outcomes with ALL. JMIR Publications 2023-05-01 /pmc/articles/PMC10186186/ /pubmed/37126376 http://dx.doi.org/10.2196/39852 Text en ©Rebecca Crawford, Slaven Sikirica, Ross Morrison, Joseph C Cappelleri, Alexander Russell-Smith, Richa Shah, Helen Chadwick, Lynda Doward. Originally published in JMIR Cancer (https://cancer.jmir.org), 01.05.2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on https://cancer.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Crawford, Rebecca Sikirica, Slaven Morrison, Ross Cappelleri, Joseph C Russell-Smith, Alexander Shah, Richa Chadwick, Helen Doward, Lynda The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: Social Media Review |
title | The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: Social Media Review |
title_full | The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: Social Media Review |
title_fullStr | The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: Social Media Review |
title_full_unstemmed | The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: Social Media Review |
title_short | The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: Social Media Review |
title_sort | patient experience of acute lymphoblastic leukemia and its treatment: social media review |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186186/ https://www.ncbi.nlm.nih.gov/pubmed/37126376 http://dx.doi.org/10.2196/39852 |
work_keys_str_mv | AT crawfordrebecca thepatientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT sikiricaslaven thepatientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT morrisonross thepatientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT cappellerijosephc thepatientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT russellsmithalexander thepatientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT shahricha thepatientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT chadwickhelen thepatientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT dowardlynda thepatientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT crawfordrebecca patientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT sikiricaslaven patientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT morrisonross patientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT cappellerijosephc patientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT russellsmithalexander patientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT shahricha patientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT chadwickhelen patientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview AT dowardlynda patientexperienceofacutelymphoblasticleukemiaanditstreatmentsocialmediareview |